Table 1.
Virus-derived circRNAs.
| Virus | Sample type | Virus-derived circRNAs | Reference |
|---|---|---|---|
| HPV | TCGA RNA-Seq data from HPV-positive cancers | HPV16 circE7 | (Zhao et al., 2019a) |
| HBV | HBV-infected HepG2 cells, HepAD38 cells and human primary hepatocytes | HBV circRNA | (Sekiba et al., 2018) |
| BCLCaV | BCLCaV-infected Ribes nigrum and Nicotiana benthamiana tissue | circular forms of BCLCaV RNA-2 and RNA-3 | (James et al., 2018) |
| rLCV SIV | SIV/LCV-infected rhesus lymphoma model | rLCV circRPMS1_E5_E3a EBV circRPMS1_E4_E3a circRPMS1_E2b_E1b circEBNA_U | (Ungerleider et al., 2019) |
| MHV68 | MHV68-infected NIH 3T12 cells | MHV68 circM11_ORF69 | |
| KSHV | KSHV positive BCBL-1 cells | KSHV circvIRF4 | |
| KSHV | KSHV-infected HUVECs or infected B cell line, MC116 | KSHV circvIRF4 | (Tagawa et al., 2018) |
| EBV | EBV-infected cell lines, including SNU-719, AGS-EBV, C666-1 and Akata | EBV circ_RPMS1 | (Huang et al., 2019) |
| EBV | Represent type I, II, and III latency transcription programs and during reactivation period lymphocyte gastric cancer cell models infected with EBV | circEBNA_U、circBHLF1 circRPMS1_E4_E3a circRPMS1_E4_E2 circEBNA_W1_C1 circEBNA_W2_C1 circLMP2_E8_E2 | (Ungerleider et al., 2018) |
| EBV | EBV-positive PTLDs | circBARTs | (Toptan et al., 2018) |
| KSHV | DMSO-treated or NaB/TPA-induced KSHV-infected PEL cell lines BCBL1 and BC-1 | circvIRF4, circPANs/K7.3 |
TCGA, The Cancer Genome Atlas; rLCV, rhesus macaque lymphocryptovirus; SIV, simian immunodeficiency virus; HUVECs, HUVEC-human umbilical vein endothelial cells; PTLD, posttransplant lymphoproliferative disease.